# SK Chemicals Co., Ltd. clinical trials: 53 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 53 trials with SK Chemicals Co., Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by SK Chemicals Co., Ltd.: 53 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sk-chemicals-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 53
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 53, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 5, 2023 | NCT05930080 | Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial | SK Chemicals Co., Ltd. | Phase 3 | Completed | Osteoarthritis, Knee | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05930080) |
| June 15, 2023 | NCT05906199 | A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf... | SK Chemicals Co., Ltd. | Phase 4 | Completed | Diabetic Peripheral Angiopathy | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05906199) |
| July 12, 2022 | NCT05453786 | A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers | SK Chemicals Co., Ltd. | Phase 1 | Completed | Healthy Subjects | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05453786) |
| July 6, 2022 | NCT05445895 | A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke | SK Chemicals Co., Ltd. | Phase 4 | Completed | Ischemic Stroke | 483 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05445895) |
| June 1, 2022 | NCT05400395 | Clinical Trial for GNX80 in Intermittent Claudication | SK Chemicals Co., Ltd. | Phase 4 | Unknown | Intermittent Claudication | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05400395) |
| February 11, 2022 | NCT05236998 | A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers | SK Chemicals Co., Ltd. | Phase 1 | Completed | Healthy Subjects | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05236998) |
| March 29, 2021 | NCT04821687 | A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in... | SK Chemicals Co., Ltd. | Phase 4 | Completed | Parkinson Disease | 169 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04821687) |
| May 26, 2020 | NCT04401137 | The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects | SK Chemicals Co., Ltd. | Phase 1 | Completed | Migraine | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04401137) |
| March 28, 2019 | NCT03893669 | Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults | SK Chemicals Co., Ltd. | Phase 1 | Completed | Prevention of Influenza | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03893669) |
| February 1, 2019 | NCT03826719 | Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers | SK Chemicals Co., Ltd. | Phase 1/2 | Completed | Influenza | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03826719) |
| October 23, 2017 | NCT03318276 | Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease | SK Chemicals Co., Ltd. | Phase 3 | Completed | Peripheral Arterial Disease | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03318276) |
| April 20, 2017 | NCT03121638 | Safety Study of NBP608 in Healthy Adult Volunteers | SK Chemicals Co., Ltd. | Phase 1 | Completed | Varicella Zoster, Immunization; Infection | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03121638) |
| April 19, 2017 | NCT03120364 | Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over | SK Chemicals Co., Ltd. | Phase 3 | Completed | Herpes Zoster | 824 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03120364) |
| April 17, 2017 | NCT03116594 | Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over | SK Chemicals Co., Ltd. | Phase 2/3 | Completed | Herpes Zoster | 675 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03116594) |
| April 14, 2017 | NCT03114982 | The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age | SK Chemicals Co., Ltd. | Phase 2 | Completed | Varicella | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03114982) |
| January 13, 2017 | NCT03020628 | Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months | SK Chemicals Co., Ltd. | Phase 3 | Completed | Influenza, Human | 171 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03020628) |
| October 7, 2016 | NCT02927444 | Immunogenicity and Safety Study of NBP606 in Healthy Toddlers | SK Chemicals Co., Ltd. | Phase 3 | Completed | Pneumococcal Infections | 462 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02927444) |
| December 9, 2015 | NCT02625714 | Safety/Tolerability and Pharmacokinetic Study of SID142 | SK Chemicals Co., Ltd. | Phase 1 | Completed | Arterial Occlusive Diseases | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02625714) |
| December 3, 2015 | NCT02621177 | Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents | SK Chemicals Co., Ltd. | Phase 3 | Completed | Influenza, Human | 385 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02621177) |
| December 3, 2015 | NCT02621164 | Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents | SK Chemicals Co., Ltd. | Phase 3 | Completed | Influenza, Human | 454 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02621164) |
| June 30, 2015 | NCT02485067 | Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB | SK Chemicals Co., Ltd. | Phase 3 | Completed | Overactive Bladder | 384 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02485067) |
| June 30, 2015 | NCT02485041 | Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg | SK Chemicals Co., Ltd. | Phase 1 | Completed | Drug Interaction Potentiation | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02485041) |
| June 30, 2015 | NCT02485028 | Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg | SK Chemicals Co., Ltd. | Phase 1 | Completed | Drug Interaction Potentiation | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02485028) |
| June 10, 2015 | NCT02467842 | Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects | SK Chemicals Co., Ltd. | Phase 3 | Completed | Influenza | 1,503 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02467842) |
| January 22, 2015 | NCT02344134 | Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects | SK Chemicals Co., Ltd. | Phase 3 | Completed | Influenza, Human | 1,155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02344134) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 17 |
| Phase 1/2 | 1 |
| Phase 2 | 7 |
| Phase 2/3 | 1 |
| Phase 3 | 22 |
| Phase 4 | 5 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 50 |
| Terminated | 2 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Influenza, Human | 6 |
| Erectile Dysfunction | 6 |
| Hypertension | 3 |
| Pneumococcal Infections | 3 |
| Herpes Zoster | 2 |
| Gout | 2 |
| Asthma | 2 |
| Osteoarthritis, Knee | 2 |
| Alzheimer Disease | 2 |
| Migraine Disorders | 2 |
| Chickenpox | 1 |
| Hepatitis B | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Infections | 1 |
| Hyperuricemia | 1 |
| Parkinson Disease | 1 |
| Intermittent Claudication | 1 |
| Arterial Occlusive Diseases | 1 |
| Peripheral Arterial Disease | 1 |
| Urinary Bladder, Overactive | 1 |
| Endometriosis | 1 |
| Irritable Bowel Syndrome | 1 |
| Constipation | 1 |
| Kidney Failure, Chronic | 1 |
| Diabetes Mellitus | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Produce wholesalers in the United States](https://specstream.ai/data/businesses/produce-wholesalers/united-states)
- [Scale suppliers in the United States](https://specstream.ai/data/businesses/scale-suppliers/united-states)
- [Surgery centers in the United States](https://specstream.ai/data/businesses/surgery-centers/united-states)
- [Ultrasound imaging clinics in the United States](https://specstream.ai/data/businesses/ultrasound-imaging-clinics/united-states)
- [3D printing companies in the United States](https://specstream.ai/data/businesses/3d-printing-companies/united-states)
- [Awning suppliers in the United States](https://specstream.ai/data/businesses/awning-suppliers/united-states)
